Pfizer (PFE) FY2023 results: revenue $59.6 billion, down 41.1% on the year
Pfizer Inc. (PFE) reported revenue of $59.6 billion for fiscal 2023, the year ended 31 December 2023, down 41.1% on the year before. Net income was $2.1 billion, down 93.2%, and diluted earnings per share $0.37. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2024.
Revenue
$59.6 billion
-41.1% on the year
FY2016FY2023
Operating margin
n/a
FY2016FY2023
Net income
$2.1 billion
-93.2% on the year
FY2016FY2023
Diluted EPS
$0.37
-93.2% on the year
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
8,700
29,267
32,580
-70.3%
Capital expenditure
3,907
3,236
2,711
+20.7%
Free cash flow
4,793
26,031
29,869
-81.6%
Free cash flow margin
8.0%
25.7%
36.7%
Cash from investing
-32,278
-15,783
-22,546
Cash from financing
26,066
-14,834
-9,816
Depreciation and amortisation
6,290
5,064
5,191
+24.2%
Share-based compensation
525
872
1,182
-39.8%
Buybacks
0.0
2,000
0.0
Dividends paid
9,247
8,983
8,729
+2.9%
Dividend per share
$1.65
$1.61
$1.57
+2.5%
Diluted shares, weighted
5,709m
5,733m
5,708m
-0.4%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
89,014
95,661
77,201
-6.9%
Non-controlling interest
274
256
262
+7.0%
Debt
71,888
35,829
38,436
+100.6%
Operating lease liabilities
2,626
2,597
2,510
+1.1%
Other liabilities
62,699
62,862
63,067
-0.3%
Total liabilities and equity
226,501
197,205
181,476
+14.9%
Fixed assets
18,940
16,274
14,882
+16.4%
Goodwill
67,783
51,375
49,208
+31.9%
Intangible assets
64,900
43,370
25,146
+49.6%
Investments
19,768
33,812
43,540
-41.5%
Cash and equivalents
2,853
416
1,944
+585.8%
Receivables
11,566
10,952
11,479
+5.6%
Inventory
10,189
8,981
9,059
+13.5%
Other assets
30,502
32,025
26,218
-4.8%
Total assets
226,501
197,205
181,476
+14.9%
10-K for the year ended 31 December 2023, filed 22 February 2024: the filing.